Nordhealth AS (NORDH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nordhealth AS (NORDH) has a cash flow conversion efficiency ratio of -0.008x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-498.00K ≈ $-52.40K USD) by net assets (Nkr61.56 Million ≈ $6.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Nordhealth AS balance sheet independence to measure how much of total assets are equity-financed.
Nordhealth AS - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Nordhealth AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Nordhealth AS cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Nordhealth AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nordhealth AS ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Polaryx Therapeutics, Inc. Common Stock
NASDAQ:PLYX
|
-0.326x |
|
Consórcio Alfa de Administração S.A
SA:BRGE3
|
0.031x |
|
WiSoL CO.LTD
KQ:122990
|
0.024x |
|
Tainergy Tech Co Ltd
TW:4934
|
-0.035x |
|
Taseco Air Services JSC
VN:AST
|
0.091x |
|
GR Silver Mining Ltd
V:GRSL
|
-0.097x |
|
Suria Capital Holdings Bhd
KLSE:6521
|
-0.009x |
|
MSM Malaysia Holdings Bhd
KLSE:5202
|
0.058x |
Annual Cash Flow Conversion Efficiency for Nordhealth AS (2020–2025)
The table below shows the annual cash flow conversion efficiency of Nordhealth AS from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see Nordhealth AS (NORDH) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Nkr61.56 Million ≈ $6.48 Million |
Nkr719.00K ≈ $75.66K |
0.012x | -53.46% |
| 2024-12-31 | Nkr73.63 Million ≈ $7.75 Million |
Nkr1.85 Million ≈ $194.46K |
0.025x | +139.77% |
| 2023-12-31 | Nkr82.77 Million ≈ $8.71 Million |
Nkr-5.22 Million ≈ $-549.61K |
-0.063x | +4.61% |
| 2022-12-31 | Nkr98.63 Million ≈ $10.38 Million |
Nkr-6.53 Million ≈ $-686.62K |
-0.066x | -236.08% |
| 2021-12-31 | Nkr114.51 Million ≈ $12.05 Million |
Nkr5.57 Million ≈ $585.81K |
0.049x | -95.67% |
| 2020-12-31 | Nkr4.95 Million ≈ $521.30K |
Nkr5.57 Million ≈ $585.81K |
1.124x | -- |
About Nordhealth AS
Nordhealth AS provides healthcare software solutions in Norway, Finland, Sweden, the United Kingdom, Denmark, Germany, and internationally. Its products include Provet Cloud, a veterinary practice management software (PMS); Diarium, a PMS for therapists that streamlines therapy sessions, booking, and invoicing; Physica, a PMS for physiotherapists; Psykbase, a PMS for psychologists and psychothera… Read more